The North America Oculoplastic Surgery Market is expected to witness market growth of 5.25% CAGR during the forecast period (2019-2025).
Oculoplastic surgery is generally performed to enhance the appearance of patients. Factors such as advances in non-invasive techniques due to benefits, including rapid recovery time and the same-day procedure, are expected to boost the market for oculoplastic surgery. Such techniques are known to dramatically reduce the incidence of postoperative complications that are supposed to work out well for overall market growth in the near future.
Growing prevalence of eye-related disorders, such as blurred vision, eye wrinkles, and droopy eyes, is anticipated to contribute to market growth. According to the American Society of Esthetic Plastic Surgery, more than 1.3 million eyelid operations were conducted worldwide in 2017. The study also points out that nearly 17 million plastic surgery procedures were conducted in the United States alone in the same year. Growing medical tourism and strengthened reimbursement policies in both developed and developing economies are projected to have a positive impact on the development of the oculoplastic surgery industry in the coming years.
Based on Procedure, the market is segmented into Eyelid Surgery, Orbital Surgery, Face Lift, Brow Lift & Forehead Lift and Pediatric Oculoplastic surgery. Based on End Use, the market is segmented into Ambulatory surgical centers and Hospitals & clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Karl Storz SE & Co. KG, Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH), Stanford Health Care, Tekno-Medical Optik-Chirurgie GmbH, Bolton Surgical Ltd., Blink Medical Ltd. (Katena Products, Inc.), and Sklar Corporation.
Scope of the Study
Market Segmentation:
By Procedure
By End Use
By Country
Companies Profiled
Unique Offerings from the Publisher
Oculoplastic surgery is generally performed to enhance the appearance of patients. Factors such as advances in non-invasive techniques due to benefits, including rapid recovery time and the same-day procedure, are expected to boost the market for oculoplastic surgery. Such techniques are known to dramatically reduce the incidence of postoperative complications that are supposed to work out well for overall market growth in the near future.
Growing prevalence of eye-related disorders, such as blurred vision, eye wrinkles, and droopy eyes, is anticipated to contribute to market growth. According to the American Society of Esthetic Plastic Surgery, more than 1.3 million eyelid operations were conducted worldwide in 2017. The study also points out that nearly 17 million plastic surgery procedures were conducted in the United States alone in the same year. Growing medical tourism and strengthened reimbursement policies in both developed and developing economies are projected to have a positive impact on the development of the oculoplastic surgery industry in the coming years.
Based on Procedure, the market is segmented into Eyelid Surgery, Orbital Surgery, Face Lift, Brow Lift & Forehead Lift and Pediatric Oculoplastic surgery. Based on End Use, the market is segmented into Ambulatory surgical centers and Hospitals & clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Karl Storz SE & Co. KG, Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH), Stanford Health Care, Tekno-Medical Optik-Chirurgie GmbH, Bolton Surgical Ltd., Blink Medical Ltd. (Katena Products, Inc.), and Sklar Corporation.
Scope of the Study
Market Segmentation:
By Procedure
- Eyelid Surgery
- Orbital Surgery
- Face Lift
- Brow Lift & Forehead Lift
- Pediatric Oculoplastic surgery
By End Use
- Ambulatory surgical centers
- Hospitals & clinics
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Zimmer Biomet Holdings, Inc.
- B. Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Karl Storz SE & Co. KG
- Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH)
- Stanford Health Care
- Tekno-Medical Optik-Chirurgie GmbH
- Bolton Surgical Ltd.
- Blink Medical Ltd. (Katena Products, Inc.)
- Sklar Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Oculoplastic Surgery Market by Procedure
Chapter 4. North America Oculoplastic Surgery Market by End Use
Chapter 5. North America Oculoplastic Surgery Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Zimmer Biomet Holdings, Inc.
- B. Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Karl Storz SE & Co. KG
- Antibe Therapeutics, Inc. (BMT Medizintechnik GmbH)
- Stanford Health Care
- Tekno-Medical Optik-Chirurgie GmbH
- Bolton Surgical Ltd.
- Blink Medical Ltd. (Katena Products, Inc.)
- Sklar Corporation
Methodology
LOADING...
